187 related articles for article (PubMed ID: 30843041)
1. Maternal Engineered Nanomaterial Inhalation During Gestation Disrupts Vascular Kisspeptin Reactivity.
Bowdridge EC; Abukabda AB; Engles KJ; McBride CR; Batchelor TP; Goldsmith WT; Garner KL; Friend S; Nurkiewicz TR
Toxicol Sci; 2019 Jun; 169(2):524-533. PubMed ID: 30843041
[TBL] [Abstract][Full Text] [Related]
2. Maternal titanium dioxide nanomaterial inhalation exposure compromises placental hemodynamics.
Abukabda AB; Bowdridge EC; McBride CR; Batchelor TP; Goldsmith WT; Garner KL; Friend S; Nurkiewicz TR
Toxicol Appl Pharmacol; 2019 Mar; 367():51-61. PubMed ID: 30711534
[TBL] [Abstract][Full Text] [Related]
3. Maternal Nanomaterial Inhalation Exposure: Critical Gestational Period in the Uterine Microcirculation is Angiotensin II Dependent.
Garner KL; Bowdridge EC; Griffith JA; DeVallance E; Seman MG; Engels KJ; Groth CP; Goldsmith WT; Wix K; Batchelor TP; Nurkiewicz TR
Cardiovasc Toxicol; 2022 Feb; 22(2):167-180. PubMed ID: 35066857
[TBL] [Abstract][Full Text] [Related]
4. Nano-titanium dioxide inhalation exposure during gestation drives redox dysregulation and vascular dysfunction across generations.
Bowdridge EC; DeVallance E; Garner KL; Griffith JA; Schafner K; Seaman M; Engels KJ; Wix K; Batchelor TP; Goldsmith WT; Hussain S; Nurkiewicz TR
Part Fibre Toxicol; 2022 Mar; 19(1):18. PubMed ID: 35260159
[TBL] [Abstract][Full Text] [Related]
5. Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure.
Fournier SB; Kallontzi S; Fabris L; Love C; Stapleton PA
Cardiovasc Toxicol; 2019 Aug; 19(4):321-333. PubMed ID: 30734150
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterial Inhalation During Pregnancy Alters Systemic Vascular Function in a Cyclooxygenase-Dependent Manner.
Griffith JA; Garner KL; Bowdridge EC; DeVallance E; Schafner KJ; Engles KJ; Batchelor TP; Goldsmith WT; Wix K; Hussain S; Nurkiewicz TR
Toxicol Sci; 2022 Jul; 188(2):219-233. PubMed ID: 35642938
[TBL] [Abstract][Full Text] [Related]
7. Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply?
Stapleton PA; Minarchick VC; Yi J; Engels K; McBride CR; Nurkiewicz TR
Am J Obstet Gynecol; 2013 Sep; 209(3):227.e1-11. PubMed ID: 23643573
[TBL] [Abstract][Full Text] [Related]
8. Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure.
Abukabda AB; McBride CR; Batchelor TP; Goldsmith WT; Bowdridge EC; Garner KL; Friend S; Nurkiewicz TR
Part Fibre Toxicol; 2018 Nov; 15(1):43. PubMed ID: 30413212
[TBL] [Abstract][Full Text] [Related]
9. Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome.
Stapleton PA; Hathaway QA; Nichols CE; Abukabda AB; Pinti MV; Shepherd DL; McBride CR; Yi J; Castranova VC; Hollander JM; Nurkiewicz TR
Part Fibre Toxicol; 2018 Jan; 15(1):3. PubMed ID: 29321036
[TBL] [Abstract][Full Text] [Related]
10. Maternal, placental, and fetal distribution of titanium after repeated titanium dioxide nanoparticle inhalation through pregnancy.
D'Errico JN; Doherty C; Reyes George JJ; Buckley B; Stapleton PA
Placenta; 2022 Apr; 121():99-108. PubMed ID: 35305398
[TBL] [Abstract][Full Text] [Related]
11. ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure.
Kunovac A; Hathaway QA; Pinti MV; Goldsmith WT; Durr AJ; Fink GK; Nurkiewicz TR; Hollander JM
Part Fibre Toxicol; 2019 Jun; 16(1):24. PubMed ID: 31215478
[TBL] [Abstract][Full Text] [Related]
12. Development of coronary dysfunction in adult progeny after maternal engineered nanomaterial inhalation during gestation.
Fournier SB; Lam V; Goedken MJ; Fabris L; Stapleton PA
Sci Rep; 2021 Sep; 11(1):19374. PubMed ID: 34588535
[TBL] [Abstract][Full Text] [Related]
13. Microvascular and mitochondrial dysfunction in the female F1 generation after gestational TiO2 nanoparticle exposure.
Stapleton PA; Nichols CE; Yi J; McBride CR; Minarchick VC; Shepherd DL; Hollander JM; Nurkiewicz TR
Nanotoxicology; 2015; 9(8):941-51. PubMed ID: 25475392
[TBL] [Abstract][Full Text] [Related]
14. Maternal nano-titanium dioxide inhalation alters fetoplacental outcomes in a sexually dimorphic manner.
Griffith JA; Dunn A; DeVallance E; Schafner KJ; Engles KJ; Batchelor TP; Goldsmith WT; Wix K; Hussain S; Bowdridge EC; Nurkiewicz TR
Front Toxicol; 2023; 5():1096173. PubMed ID: 36950144
[TBL] [Abstract][Full Text] [Related]
15. Maternal nano-titanium dioxide inhalation exposure alters placental cyclooxygenase and oxidant balance in a sexually dimorphic manner.
Griffith JA; King RD; Dunn AC; Lewis SE; Maxwell BA; Nurkiewicz TR; Goldsmith WT; Kelley EE; Bowdridge EC
Adv Redox Res; 2024 Apr; 10():. PubMed ID: 38562524
[TBL] [Abstract][Full Text] [Related]
16. Maternal exposure to nanosized titanium dioxide suppresses embryonic development in mice.
Hong F; Zhou Y; Zhao X; Sheng L; Wang L
Int J Nanomedicine; 2017; 12():6197-6204. PubMed ID: 28883729
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure.
Abukabda AB; Stapleton PA; McBride CR; Yi J; Nurkiewicz TR
Front Cardiovasc Med; 2017; 4():33. PubMed ID: 28596957
[TBL] [Abstract][Full Text] [Related]
18. Gestational exposure to titanium dioxide nanoparticles impairs the placentation through dysregulation of vascularization, proliferation and apoptosis in mice.
Zhang L; Xie X; Zhou Y; Yu D; Deng Y; Ouyang J; Yang B; Luo D; Zhang D; Kuang H
Int J Nanomedicine; 2018; 13():777-789. PubMed ID: 29440900
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity studies with 6 forms of titanium dioxide test materials (3 pigment-different grade & 3 nanoscale) demonstrate an absence of effects in orally-exposed rats.
Warheit DB; Boatman R; Brown SC
Regul Toxicol Pharmacol; 2015 Dec; 73(3):887-96. PubMed ID: 26434710
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary particulate matter and systemic microvascular dysfunction.
Nurkiewicz TR; Porter DW; Hubbs AF; Stone S; Moseley AM; Cumpston JL; Goodwill AG; Frisbee SJ; Perrotta PL; Brock RW; Frisbee JC; Boegehold MA; Frazer DG; Chen BT; Castranova V;
Res Rep Health Eff Inst; 2011 Dec; (164):3-48. PubMed ID: 22329339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
